Stephen Pandol to Antineoplastic Agents
This is a "connection" page, showing publications Stephen Pandol has written about Antineoplastic Agents.
Connection Strength
1.063
-
An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice. Gastroenterology. 2018 12; 155(6):1985-1998.e5.
Score: 0.538
-
Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse model. Gynecol Oncol. 2020 10; 159(1):277-284.
Score: 0.153
-
Macrophages and pancreatic ductal adenocarcinoma. Cancer Lett. 2016 10 10; 381(1):211-6.
Score: 0.112
-
The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis. PLoS One. 2015; 10(4):e0121783.
Score: 0.106
-
Apigenin inhibits NNK-induced focal adhesion kinase activation in pancreatic cancer cells. Pancreas. 2012 Nov; 41(8):1306-15.
Score: 0.090
-
Prevention of metastatic pancreatic cancer growth in vivo by induction of apoptosis with genistein, a naturally occurring isoflavonoid. Pancreas. 2003 Apr; 26(3):264-73.
Score: 0.046
-
Rottlerin stimulates apoptosis in pancreatic cancer cells through interactions with proteins of the Bcl-2 family. Am J Physiol Gastrointest Liver Physiol. 2010 Jan; 298(1):G63-73.
Score: 0.018